Bennu Oil & Gas, LLC’s $700 Million Acquisition/$350 Million Credit Facility
November 06, 2013
On November 1, 2013, Bennu Oil & Gas, LLC completed its approximately $700 million acquisition of all the Gulf of Mexico oil and gas assets of ATP Oil & Gas Corporation. The transaction was effected pursuant to a “credit bid” under section 363 of the Bankruptcy Code. Bennu was formed by the lenders under ATP’s debtor‑in‑possession (DIP) credit facility to effect the acquisition. Cravath represented Credit Suisse AG throughout ATP’s bankruptcy case in its capacity as administrative agent under ATP’s DIP facility (including in connection with various litigation matters relating to the case), as well in connection with Credit Suisse’s arrangement of a $350 million credit facility provided to Bennu to finance the acquisition and related transactions.
The Cravath team included partner Paul H. Zumbro and associates Benjamin P. Schaye, Stephanie R. Tumbiolo, Wesley C. Bell and Peter J. Atlee on bankruptcy and financing matters; partner Julie A. North and associate Greg C. Cheyne on litigation matters; and partner J. Leonard Teti II and associate Neetin Gulati on tax matters. Michael L. Arnold also worked on financing matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1997, Columbia Law SchoolHarlan Fiske Stone Scholar
-
B.A., 1992, Yale CollegeDistinction in Major, cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2005, University of Virginia School of LawOrder of the Coif
-
A.B., 1999, Princeton Universitywith Honors
- New York
Education
Admitted In
- Photo
-
-
J.D., 1989, Syracuse University College of Lawmagna cum laude
-
B.A., 1984, Hamilton Collegecum laude
Education
Related News & Insights
Deals & Cases
July 13, 2026
Boluda Towage’s €2.45 Billion Term Loan and Revolving Credit Facilities
Cravath represented the agent, mandated lead arrangers and lenders in connection with Boluda Towage’s €2.15 billion (equivalent) term loan facility and €300 million multi‑currency revolving credit facility. The proceeds will be used towards refinancing certain existing credit facilities and for general corporate purposes. Boluda Towage is a leading maritime services operator. The transaction closed on June 30, 2026.
Deals & Cases
April 06, 2026
Versigent’s $1.35 Billion Credit Facilities and $1.6 Billion High‑Yield Senior Notes Offering in Connection with Aptiv PLC’s Spin‑Off of Versigent
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $1.35 billion of credit facilities made available to subsidiaries of Versigent Limited, a global leader in the design, development and manufacture of low voltage and high voltage electrical architectures and the holding company for Aptiv PLC’s Electrical Distribution Systems segment, which Aptiv PLC spun off into a separate, independent, publicly traded company. The proceeds were used to partially finance the spin‑off. The credit facilities consisted of a $500 million term loan facility and an $850 million revolving credit facility. The transaction closed on November 26, 2025.
Deals & Cases
February 20, 2026
First Solar’s $1.5 Billion Revolving Credit Facility
Cravath represented First Solar, Inc. in connection with its $1.5 billion revolving credit facility. First Solar is America’s leading photovoltaic solar technology and manufacturing company, and the only US‑headquartered company among the world’s largest solar manufacturers. The transaction closed on February 13, 2026.
Deals & Cases
January 08, 2026
Genmab’s $3.5 Billion of Credit Facilities and Offering of $1.5 Billion Senior Secured Notes and $1 Billion Senior Unsecured Notes in Connection with its Acquisition of Merus
Cravath represented the administrative agent, joint lead arrangers and joint bookrunners in connection with $3.5 billion of credit facilities made available to Genmab, a leading international biotechnology company, and one of its wholly‑owned subsidiaries, Genmab Finance LLC, as part of the financing transactions undertaken in connection with its acquisition of Merus N.V., a leading oncology company developing innovative antibody therapeutics. The credit facilities consisted of a $2 billion term loan “B” facility, a $1 billion term loan “A” facility and a $500 million revolving credit facility. The transaction closed on December 12, 2025.
